INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Ipca Laboratories Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 524494	ISIN Demat INE571A01038	Book Value 265.61	NSE Symbol IPCALAB	Dividend Yield (%) 0.3	Market Cap (₹ Cr.) 33,785.79	P/E 40.77	EPS 32.66	Face Value 1

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021	Mar2020
Revenue From Operations	6,166.46	5,814.62	5,438.30	5,139.16	4,367.43
Sale of Products	6,114.14	5,770.73	5,368.17	5,077.30	4,302.75
Sale of Services	7.65	6.45	6.93	7.89	4.54
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	44.67	37.44	63.20	53.97	60.14
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	29.61
Revenue From Operations - Net	6,166.46	5,814.62	5,438.30	5,139.16	4,337.82
Other Income	111.29	111.19	52.92	62.24	64.69
Total Revenue	6,277.75	5,925.81	5,491.22	5,201.40	4,402.51
Changes in Inventories	-55.19	104.09	-126.00	-170.73	-155.05
Cost of Material Consumed	1,688.36	1,684.03	1,628.52	1,555.53	1,431.10
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	345.21	280.91	283.36	197.68	204.65
Employee Benefits	1,336.19	1,193.39	1,102.14	948.84	870.79
Total Other Expenses	1,640.51	1,640.35	1,312.20	1,094.26	1,071.57
Manufacturing / Operating Expenses	610.14	588.95	516.47	426.73	395.12
Administrative and Selling Expenses	846.95	812.67	612.89	551.23	523.99
Other Expenses	183.42	238.73	182.84	116.30	152.46
Finance Costs	120.67	43.92	7.24	8.14	15.79
Depreciation and Amortization	246.48	228.63	209.65	187.72	178.69
Total Expenses	5,322.23	5,175.32	4,417.11	3,821.44	3,617.54
Profit Before Exceptional Items and Tax	955.52	750.49	1,074.11	1,379.96	784.97
Exceptional Items Before Tax	-133.36	0.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	822.16	750.49	1,074.11	1,379.96	784.97
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	822.16	750.49	1,074.11	1,379.96	784.97
Taxation	291.75	244.79	213.74	239.19	132.51
Current Tax	291.00	223.95	197.20	244.98	137.98
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	3.74	20.84	16.46	-5.79	-5.47
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	-2.99	0.00	0.08	0.00	0.00
Profit After Tax	530.41	505.70	860.37	1,140.77	652.46
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	530.41	505.70	860.37	1,140.77	652.46
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	530.41	505.70	860.37	1,140.77	652.46
Earning Per Share - Basic	20.91	19.93	33.91	45.04	51.64
Earning Per Share - Diluted	20.91	19.93	33.91	45.04	51.60
Operation Profit before Depreciation	1,322.67	1,023.04	1,291.00	1,575.82	979.45
Operating Profit after Depreciation	1,076.19	794.41	1,081.35	1,388.10	800.76
Dividend Per Share	4.00	4.00	4.00	8.00	5.00
Dividend Percentage	400.00	400.00	400.00	400.00	250.00
Equity Dividend	101.48	101.48	101.48	101.48	63.18
Weighted Average Shares - Basic	25.37	25.37	25.37	25.33	12.63
Weighted Average Shares - Diluted	25.37	25.37	25.37	25.33	12.64